Literature DB >> 29755011

Autophagy and liver cancer.

Yunus Akkoç1, Devrim Gözüaçık1.   

Abstract

Autophagy is a key biological phenomenon conserved from yeast to mammals. Under basal conditions, activation of autophagy leads to the protein degradation as well as damaged organelles for maintaining cellular homeostasis. Deregulation of autophagy has been identified as a key mechanism contributing to the pathogenesis and progression of several liver diseases, including hepatocellular carcinoma (HCC), one of the most common and mortal types of cancer. Currently used treatment strategies in patients with HCC result in variable success rates. Therefore, novel early diagnosis and treatment techniques should be developed. Manipulation of autophagy may improve responses of cancer cell to treatments and provide novel targeted therapy options for HCC. In this review, we summarized how our understanding of autophagy-cell death connection may have an impact on HCC therapy.

Entities:  

Mesh:

Year:  2018        PMID: 29755011      PMCID: PMC6284658          DOI: 10.5152/tjg.2018.150318

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  14 in total

Review 1.  Autophagy and Hepatic Tumor Microenvironment Associated Dormancy.

Authors:  Yunus Akkoc; Devrim Gozuacik
Journal:  J Gastrointest Cancer       Date:  2021-12-18

2.  Autophagy-related genes contribute to malignant progression and have a clinical prognostic impact in colon adenocarcinoma.

Authors:  Xianyi Zhang; Runtao Xu; Wenjing Feng; Jiapeng Xu; Yulong Liang; Jinghui Mu
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

3.  The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells.

Authors:  Jialiang Wang; Huan Wei; Yanlin Huang; Dongmei Chen; Guofen Zeng; Yifan Lian; Yuehua Huang
Journal:  Aging (Albany NY)       Date:  2019-08-13       Impact factor: 5.682

Review 4.  Nanomaterial-mediated autophagy: coexisting hazard and health benefits in biomedicine.

Authors:  Xiaoli Feng; Yaqing Zhang; Chao Zhang; Xuan Lai; Yanli Zhang; Junrong Wu; Chen Hu; Longquan Shao
Journal:  Part Fibre Toxicol       Date:  2020-10-16       Impact factor: 9.400

Review 5.  Emerging Roles of Impaired Autophagy in Fatty Liver Disease and Hepatocellular Carcinoma.

Authors:  Suryakant Niture; Minghui Lin; Leslimar Rios-Colon; Qi Qi; John T Moore; Deepak Kumar
Journal:  Int J Hepatol       Date:  2021-04-22

6.  Combining Everolimus and Ku0063794 Promotes Apoptosis of Hepatocellular Carcinoma Cells via Reduced Autophagy Resulting from Diminished Expression of miR-4790-3p.

Authors:  Ho Joong Choi; Jung Hyun Park; Ok-Hee Kim; Kee-Hwan Kim; Ha Eun Hong; Haeyeon Seo; Say-June Kim
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

7.  Epibrassinolide activates AKT to trigger autophagy with polyamine metabolism in SW480 and DLD-1 colon cancer cell lines.

Authors:  Kaan Adacan; Pınar Obakan Yerlİkaya
Journal:  Turk J Biol       Date:  2020-12-14

8.  CCAT2 enhances autophagy-related invasion and metastasis via regulating miR-4496 and ELAVL1 in hepatocellular carcinoma.

Authors:  Jing Shi; Cao Guo; Junli Ma
Journal:  J Cell Mol Med       Date:  2021-08-19       Impact factor: 5.310

9.  Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.

Authors:  Gábor Lendvai; Tímea Szekerczés; Ildikó Illyés; Milán Csengeri; Krisztina Schlachter; Erzsébet Szabó; Gábor Lotz; András Kiss; Katalin Borka; Zsuzsa Schaff
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

10.  Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis.

Authors:  Mengyao Ma; Wenhua Xie; Xi Li
Journal:  Int J Gen Med       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.